Key result
Connexins and other fundamental mechanisms of atrial fibrillation are the focus of ongoing research aimed at developing novel and more successful therapeutic options.
Key points are not available for this paper at this time.
A trial fibrillation (AF) is an extremely common arrhyth- mia with important consequences and presently suboptimal therapeutic options. 1 A great deal of research has been performed to understand the detailed mechanisms of AF, with the hope that a better appreciation of the fundamental determinants of arrhythmogenesis will lead to the development of novel, more successful treatment possibilities.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2011) studied this question. Connexins and other fundamental mechanisms of atrial fibrillation are the focus of ongoing research aimed at developing novel and more successful therapeutic options.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: